ghk-cu copper peptide hair growth clinical study randomized trial human ghk-cu hair growth clinical ghk-cu copper peptide hair growth

Research models indicate that BPC-157 may interact with intracellular signaling systems relevant to vascular growth via angiogenic signaling and inflammatory regulation via attenuation of pro-inflammatory pathways

Also known as Bepecin, BPC 157, Body Protection Compound 157, Pentadecapeptide BPC-157, PCO-02 Evidence records Studies, registries, reviews, and regulatory records Registered human trials NCT02637284 is a Phase 1 oral safety and pharmacokinetics study in healthy volunteers

TB-500 and GHK-Cu have favorable preclinical safety data but lack human safety studies

IGF-1 LR3 Reconstitution Reference (1 mg / 1,000 mcg vial) BAC water added 1 mL Concentration 1,000 mcg/mL 20 mcg dose 0.02 mL (2 units) 40 mcg dose 0.04 mL (4 units) 50 mcg dose 0.05 mL (5 units) 80 mcg dose 0.08 mL (8 units) 100 mcg dose 0.10 mL (10 units) BAC water added 2 mL Concentration 500 mcg/mL 20 mcg dose 0.04 mL (4 units) 40 mcg dose 0.08 mL (8 units) 50 mcg dose 0.10 mL (10 units) 80 mcg dose 0.16 mL (16 units) 100 mcg dose 0.20 mL (20 units) BAC water added 3 mL Concentration 333 mcg/mL 20 mcg dose 0.06 mL (6 units) 40 mcg dose 0.12 mL (12 units) 50 mcg dose 0.15 mL (15 units) 80 mcg dose 0.24 mL (24 units) 100 mcg dose 0.30 mL (30 units) Units refer to U-100 insulin syringe markings

Starting at the lower end allows assessment of individual response before increasing if needed

The choice depends on your skin type, concerns, and health goals